Immunoglobulin replacement therapy shows no reduction in serious infections for chronic lymphocytic leukemia

In patients with chronic lymphocytic leukemia (CLL), regular treatment with immunoglobulin replacement therapy was not associated with a reduced risk of serious infections requiring hospitalization, according to a study published in Blood Advances.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup